Lykan BioScience

Pioneering advancement in cell-based therapy development and manufacturing services

General Information
Company Name
Lykan BioScience
Founded Year
2019
Location (Offices)
+1
Founders / Decision Makers
Number of Employees
201-500
Industries
Biotechnology, Manufacturing
Funding Stage
Private Equity
Social Media

Lykan BioScience - Company Profile

Lykan BioScience is an innovative contract development and manufacturing services organization (CDMO) focusing on cell-based therapies. Pioneering advancement in cell-based therapy development and manufacturing services, the company was founded in 2019 and operates in the Biotechnology and Manufacturing industries. In a Private Equity Round investment at 04 August 2022, the company secured funding from Pleasant Bay Capital Partners, GHO Capital, and WindRose Health Investors. This strategic investment signifies support and confidence from established industry players, positioning Lykan BioScience for further growth and advancements in the field of cell-based therapies.

Taxonomy: cell-based therapy, CDMO, manufacturing services, cell therapy, gene therapy, innovation, advanced technology, medical development

Funding Rounds & Investors of Lykan BioScience (2)

View All
Funding Stage Amount No. Investors Investors Date
Private Equity Round Unknown 3 04 Aug 2022
Private Equity Round Unknown 1 04 Jun 2019

Latest News of Lykan BioScience

View All

No recent news or press coverage available for Lykan BioScience.

Similar Companies to Lykan BioScience

View All
Quell Therapeutics - Similar company to Lykan BioScience
Quell Therapeutics Transformational Therapies, Transforming Lives
SelCell - Similar company to Lykan BioScience
SelCell Pioneering the future of cell preservation and therapy with advanced research solutions and specialized services.
Tessa Therapeutics Ltd - Similar company to Lykan BioScience
Tessa Therapeutics Ltd A clinical-stage biotech company developing autologous and allogeneic cell therapies for the treatment of cancer.
Be Biopharma - Similar company to Lykan BioScience
Be Biopharma Engineered B cells as medicines
CytoArm|BsAb Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment - Similar company to Lykan BioScience
CytoArm|BsAb Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment Innovative BsAb Armed-T therapy platform utilizes non-viral bi-functional antibodies (BsAb) to empower T cells.